The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins
The objective of this work was to determine the role that charge might play in the interaction of charged and uncharged drugs with neutral (2-hydroxypropyl-beta-cyclodextrin, HP-beta-CD) and anionically charged (SBE7-beta-CD) modified beta-cyclodextrins. SBE7-beta-CD is a sulfobutyl ether, sodium sa...
Gespeichert in:
Veröffentlicht in: | Pharmaceutical research 1996-02, Vol.13 (2), p.256-264 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 264 |
---|---|
container_issue | 2 |
container_start_page | 256 |
container_title | Pharmaceutical research |
container_volume | 13 |
creator | OKIMOTO, K RAJEWSKI, R. A UEKAMA, K JONA, J. A STELLA, V. J |
description | The objective of this work was to determine the role that charge might play in the interaction of charged and uncharged drugs with neutral (2-hydroxypropyl-beta-cyclodextrin, HP-beta-CD) and anionically charged (SBE7-beta-CD) modified beta-cyclodextrins. SBE7-beta-CD is a sulfobutyl ether, sodium salt, derivative variably substituted on the 2-, 3- and the 6-positions of beta-cyclodextrin. The number seven refers to the average degree of substitution.
The binding of the acidic drugs, indomethacin, naproxen and warfarin and the basic drugs, papaverine, thiabendazole, miconazole and cinnarizine with the two cyclodextrins was determined at 25 degrees C as a function of pH and cyclodextrin concentration by the phase-solubility method.
Except for miconazole and cinnarizine (Ap-type diagrams), all other materials studied displayed AL-type diagrams. By comparing the binding constants of both the charged and uncharged forms of the same drugs to both HP-beta-CD and SBE7-beta-CD, the following conclusions could be drawn. The binding constants for the neutral forms of the drugs were always greater with SBE7-beta-CD than with HP-beta-CD. For the anionic agents, the binding constants between SBE7-beta-CD and HP-beta-CD were similar while the binding constants for the cationic agents with SBE7-beta-CD were superior to those of HP-beta-CD, especially when compared with the neutral form of the same drug.
A clear charge effect on complexation, attraction in the case of cationic drugs and perhaps inhibition in the case of anionic drugs, was seen with the SBE7-beta-CD. |
doi_str_mv | 10.1023/A:1016047215907 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_8932446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>8932446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c281t-fc635bf53407eb778142d00f57c9b5bccac4ad95dd93a30ab08c9adeb7d44a493</originalsourceid><addsrcrecordid>eNo9kMFKAzEURYMotVbXroQsXNTF6MskaSbu2lqtUFCwgrvyJsm0I9O0ZGbQgl_lh_hNDtp2dXncw-FxCTlncM0g5jf9WwasB0LFTGpQB6TNpOKRBvF2SNqgYhElSrBjclKW7wCQMC1apJVoHgvRa5Ov6cLR3FcuoKnylaerjJoFhrmzFL2ltd9dNtTzkn7k1YJ6V1cBC9odP0c_39Hw7uqPRd8IcoNFsdk7ui-DkdpBTZiNKVbWfVYh9-UpOcqwKN3ZNjvk9X40HY6jydPD47A_iUycsCrKTI_LNJNcgHKpUgkTsQXIpDI6lakxaARaLa3VHDlgConRaBvUCoFC8w65-Peu63Tp7Gwd8iWGzWy7QtNfbnssm_ezgN7k5R6LtZbNxvwXgi1t2A</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>OKIMOTO, K ; RAJEWSKI, R. A ; UEKAMA, K ; JONA, J. A ; STELLA, V. J</creator><creatorcontrib>OKIMOTO, K ; RAJEWSKI, R. A ; UEKAMA, K ; JONA, J. A ; STELLA, V. J</creatorcontrib><description>The objective of this work was to determine the role that charge might play in the interaction of charged and uncharged drugs with neutral (2-hydroxypropyl-beta-cyclodextrin, HP-beta-CD) and anionically charged (SBE7-beta-CD) modified beta-cyclodextrins. SBE7-beta-CD is a sulfobutyl ether, sodium salt, derivative variably substituted on the 2-, 3- and the 6-positions of beta-cyclodextrin. The number seven refers to the average degree of substitution.
The binding of the acidic drugs, indomethacin, naproxen and warfarin and the basic drugs, papaverine, thiabendazole, miconazole and cinnarizine with the two cyclodextrins was determined at 25 degrees C as a function of pH and cyclodextrin concentration by the phase-solubility method.
Except for miconazole and cinnarizine (Ap-type diagrams), all other materials studied displayed AL-type diagrams. By comparing the binding constants of both the charged and uncharged forms of the same drugs to both HP-beta-CD and SBE7-beta-CD, the following conclusions could be drawn. The binding constants for the neutral forms of the drugs were always greater with SBE7-beta-CD than with HP-beta-CD. For the anionic agents, the binding constants between SBE7-beta-CD and HP-beta-CD were similar while the binding constants for the cationic agents with SBE7-beta-CD were superior to those of HP-beta-CD, especially when compared with the neutral form of the same drug.
A clear charge effect on complexation, attraction in the case of cationic drugs and perhaps inhibition in the case of anionic drugs, was seen with the SBE7-beta-CD.</description><identifier>ISSN: 0724-8741</identifier><identifier>EISSN: 1573-904X</identifier><identifier>DOI: 10.1023/A:1016047215907</identifier><identifier>PMID: 8932446</identifier><identifier>CODEN: PHREEB</identifier><language>eng</language><publisher>New York, NY: Springer</publisher><subject>2-Hydroxypropyl-beta-cyclodextrin ; Anions ; beta-Cyclodextrins ; Biological and medical sciences ; Carbohydrate Sequence ; Chemical Phenomena ; Chemistry, Physical ; Cyclodextrins - chemistry ; Cyclodextrins - metabolism ; Drug Interactions ; General pharmacology ; Kinetics ; Medical sciences ; Molecular Sequence Data ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Solubility</subject><ispartof>Pharmaceutical research, 1996-02, Vol.13 (2), p.256-264</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c281t-fc635bf53407eb778142d00f57c9b5bccac4ad95dd93a30ab08c9adeb7d44a493</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2995160$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8932446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>OKIMOTO, K</creatorcontrib><creatorcontrib>RAJEWSKI, R. A</creatorcontrib><creatorcontrib>UEKAMA, K</creatorcontrib><creatorcontrib>JONA, J. A</creatorcontrib><creatorcontrib>STELLA, V. J</creatorcontrib><title>The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins</title><title>Pharmaceutical research</title><addtitle>Pharm Res</addtitle><description>The objective of this work was to determine the role that charge might play in the interaction of charged and uncharged drugs with neutral (2-hydroxypropyl-beta-cyclodextrin, HP-beta-CD) and anionically charged (SBE7-beta-CD) modified beta-cyclodextrins. SBE7-beta-CD is a sulfobutyl ether, sodium salt, derivative variably substituted on the 2-, 3- and the 6-positions of beta-cyclodextrin. The number seven refers to the average degree of substitution.
The binding of the acidic drugs, indomethacin, naproxen and warfarin and the basic drugs, papaverine, thiabendazole, miconazole and cinnarizine with the two cyclodextrins was determined at 25 degrees C as a function of pH and cyclodextrin concentration by the phase-solubility method.
Except for miconazole and cinnarizine (Ap-type diagrams), all other materials studied displayed AL-type diagrams. By comparing the binding constants of both the charged and uncharged forms of the same drugs to both HP-beta-CD and SBE7-beta-CD, the following conclusions could be drawn. The binding constants for the neutral forms of the drugs were always greater with SBE7-beta-CD than with HP-beta-CD. For the anionic agents, the binding constants between SBE7-beta-CD and HP-beta-CD were similar while the binding constants for the cationic agents with SBE7-beta-CD were superior to those of HP-beta-CD, especially when compared with the neutral form of the same drug.
A clear charge effect on complexation, attraction in the case of cationic drugs and perhaps inhibition in the case of anionic drugs, was seen with the SBE7-beta-CD.</description><subject>2-Hydroxypropyl-beta-cyclodextrin</subject><subject>Anions</subject><subject>beta-Cyclodextrins</subject><subject>Biological and medical sciences</subject><subject>Carbohydrate Sequence</subject><subject>Chemical Phenomena</subject><subject>Chemistry, Physical</subject><subject>Cyclodextrins - chemistry</subject><subject>Cyclodextrins - metabolism</subject><subject>Drug Interactions</subject><subject>General pharmacology</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Solubility</subject><issn>0724-8741</issn><issn>1573-904X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kMFKAzEURYMotVbXroQsXNTF6MskaSbu2lqtUFCwgrvyJsm0I9O0ZGbQgl_lh_hNDtp2dXncw-FxCTlncM0g5jf9WwasB0LFTGpQB6TNpOKRBvF2SNqgYhElSrBjclKW7wCQMC1apJVoHgvRa5Ov6cLR3FcuoKnylaerjJoFhrmzFL2ltd9dNtTzkn7k1YJ6V1cBC9odP0c_39Hw7uqPRd8IcoNFsdk7ui-DkdpBTZiNKVbWfVYh9-UpOcqwKN3ZNjvk9X40HY6jydPD47A_iUycsCrKTI_LNJNcgHKpUgkTsQXIpDI6lakxaARaLa3VHDlgConRaBvUCoFC8w65-Peu63Tp7Gwd8iWGzWy7QtNfbnssm_ezgN7k5R6LtZbNxvwXgi1t2A</recordid><startdate>19960201</startdate><enddate>19960201</enddate><creator>OKIMOTO, K</creator><creator>RAJEWSKI, R. A</creator><creator>UEKAMA, K</creator><creator>JONA, J. A</creator><creator>STELLA, V. J</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19960201</creationdate><title>The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins</title><author>OKIMOTO, K ; RAJEWSKI, R. A ; UEKAMA, K ; JONA, J. A ; STELLA, V. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c281t-fc635bf53407eb778142d00f57c9b5bccac4ad95dd93a30ab08c9adeb7d44a493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>2-Hydroxypropyl-beta-cyclodextrin</topic><topic>Anions</topic><topic>beta-Cyclodextrins</topic><topic>Biological and medical sciences</topic><topic>Carbohydrate Sequence</topic><topic>Chemical Phenomena</topic><topic>Chemistry, Physical</topic><topic>Cyclodextrins - chemistry</topic><topic>Cyclodextrins - metabolism</topic><topic>Drug Interactions</topic><topic>General pharmacology</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Solubility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>OKIMOTO, K</creatorcontrib><creatorcontrib>RAJEWSKI, R. A</creatorcontrib><creatorcontrib>UEKAMA, K</creatorcontrib><creatorcontrib>JONA, J. A</creatorcontrib><creatorcontrib>STELLA, V. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Pharmaceutical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>OKIMOTO, K</au><au>RAJEWSKI, R. A</au><au>UEKAMA, K</au><au>JONA, J. A</au><au>STELLA, V. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins</atitle><jtitle>Pharmaceutical research</jtitle><addtitle>Pharm Res</addtitle><date>1996-02-01</date><risdate>1996</risdate><volume>13</volume><issue>2</issue><spage>256</spage><epage>264</epage><pages>256-264</pages><issn>0724-8741</issn><eissn>1573-904X</eissn><coden>PHREEB</coden><abstract>The objective of this work was to determine the role that charge might play in the interaction of charged and uncharged drugs with neutral (2-hydroxypropyl-beta-cyclodextrin, HP-beta-CD) and anionically charged (SBE7-beta-CD) modified beta-cyclodextrins. SBE7-beta-CD is a sulfobutyl ether, sodium salt, derivative variably substituted on the 2-, 3- and the 6-positions of beta-cyclodextrin. The number seven refers to the average degree of substitution.
The binding of the acidic drugs, indomethacin, naproxen and warfarin and the basic drugs, papaverine, thiabendazole, miconazole and cinnarizine with the two cyclodextrins was determined at 25 degrees C as a function of pH and cyclodextrin concentration by the phase-solubility method.
Except for miconazole and cinnarizine (Ap-type diagrams), all other materials studied displayed AL-type diagrams. By comparing the binding constants of both the charged and uncharged forms of the same drugs to both HP-beta-CD and SBE7-beta-CD, the following conclusions could be drawn. The binding constants for the neutral forms of the drugs were always greater with SBE7-beta-CD than with HP-beta-CD. For the anionic agents, the binding constants between SBE7-beta-CD and HP-beta-CD were similar while the binding constants for the cationic agents with SBE7-beta-CD were superior to those of HP-beta-CD, especially when compared with the neutral form of the same drug.
A clear charge effect on complexation, attraction in the case of cationic drugs and perhaps inhibition in the case of anionic drugs, was seen with the SBE7-beta-CD.</abstract><cop>New York, NY</cop><pub>Springer</pub><pmid>8932446</pmid><doi>10.1023/A:1016047215907</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0724-8741 |
ispartof | Pharmaceutical research, 1996-02, Vol.13 (2), p.256-264 |
issn | 0724-8741 1573-904X |
language | eng |
recordid | cdi_pubmed_primary_8932446 |
source | MEDLINE; SpringerNature Journals |
subjects | 2-Hydroxypropyl-beta-cyclodextrin Anions beta-Cyclodextrins Biological and medical sciences Carbohydrate Sequence Chemical Phenomena Chemistry, Physical Cyclodextrins - chemistry Cyclodextrins - metabolism Drug Interactions General pharmacology Kinetics Medical sciences Molecular Sequence Data Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Solubility |
title | The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A13%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20interaction%20of%20charged%20and%20uncharged%20drugs%20with%20neutral%20(HP-%CE%B2-CD)%20and%20anionically%20charged%20(SBE7-%CE%B2-CD)%20%CE%B2-cyclodextrins&rft.jtitle=Pharmaceutical%20research&rft.au=OKIMOTO,%20K&rft.date=1996-02-01&rft.volume=13&rft.issue=2&rft.spage=256&rft.epage=264&rft.pages=256-264&rft.issn=0724-8741&rft.eissn=1573-904X&rft.coden=PHREEB&rft_id=info:doi/10.1023/A:1016047215907&rft_dat=%3Cpubmed_pasca%3E8932446%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/8932446&rfr_iscdi=true |